The Influence of Recombinant Bovine Somatotropin (rbST) on the Metabolic Profile and Milk Composition of Lactating Murrah Buffalo

Author:

Feckinghaus Marcelo Arne1,Diogo Mariana Guimarães de Oliveira2,Storillo Vanessa Martins2,Pogliani Fabio Celidonio1ORCID,Monteiro Bruno Moura1ORCID,Fantinato Neto Paulo2,Yasuoka Melina Marie2ORCID,Birgel Daniela Becker3,Birgel Junior Eduardo Harry3ORCID

Affiliation:

1. Department of Internal Medicine, School of Veterinary Medicine and Animal Sciences, University of São Paulo, 87 Professor Orlando Marques de Paiva Avenue, São Paulo 05508-010, SP, Brazil

2. Department of Surgery, School of Veterinary Medicine and Animal Sciences, University of São Paulo, 87 Professor Orlando Marques de Paiva Avenue, São Paulo 05508-010, SP, Brazil

3. Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of São Paulo, 225 Duque de Caxias, Pirassununga 13635-900, SP, Brazil

Abstract

The use of recombinant bovine somatotropin (rbST) leads to an increase in variable amounts of milk production in buffalo, but there is a lack of information on the influence of rbST on their metabolism. This study looked at the effects of a single 500 mg dose of rbST on the lipid profile, liver and kidney function, and physical, chemical, and cellular constitution of milk in 14 buffalo over 14 days, from the 100th day of lactation, compared with 14 animals in a control group. From the first day after rbST, there was a rise in beta-hydroxybutyrate (β-HBO), possibly due to higher dry matter intake or the biotransformation of NEFA into β-HBO. The treatment did not influence blood glucose, non-esterified fatty acids (NEFAs), triglycerides, cholesterol, total protein, albumin, AST, GGT, bilirubin, urea, or creatinine levels. In 71.3% of the buffalo, there was a gradual increase in milk production, with the maximal response occurring in the first week followed by a gradual decrease, whilst in 21.4%, the increase in production occurred between 7 and 10 days. Only 7.1% of the animals did not respond. On the 3rd, 5th, 7th, and 10th days after treatment, an increase was found in daily milk production between the two groups equal to 1.04, 1.52, 1.42, and 1.06 L, respectively. In relative terms, this means an increase in milk production, respectively, of 15.1%, 21.0%, 19.8%, and 15.1%. The constitution of the milk showed no difference in the amounts of fat, lactose, total solids, or somatic cell count; however, on the third day after rbST administration, there was a decrease in protein. Notably, from the fifth day, the protein values showed no statistical difference. It can be concluded that the use of rbST in buffalo from the 100th day of lactation is metabolically safe since the treatment neither caused imbalances in fat metabolism nor overloaded the liver or renal function, and the changes in milk composition were transient and limited to a decrease in milk protein.

Funder

São Paulo Research Foundation

Publisher

MDPI AG

Reference46 articles.

1. Valores econômicos para as características de leite de búfalas no estado de São Paulo;Seno;Rev. Bras. Zootec.,2017

2. Jorge, A.M., Couto, A.G., Crudeli, G.A., and Patiño, E.M. (2011). Produção de Búfalas de Leite, FEPAF.

3. Uso de somatotropina bovina em búfalas: Efeitos sobre a produção e composição do leite;Fernandes;Rev. Eletrônica Nutr.,2009

4. Lactation performance of Holstein cows treated with 2 formulations of recombinant bovine somatotropin in a large commercial dairy herd in Brazil;Morais;J. Dairy Sci.,2017

5. Efeito da somatotropina bovina recombinante (Rbst) sobre o desempenho produtivo e reprodutivo de vacas da raça Holandesa;Lucci;Arq. Bras. Med. Veterinária Zootec.,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3